Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2): an update and perspective
Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH1/2) reduces α-KG to the oncometabolite 2-hydroxyglutarate (2-HG). High levels of 2-HG competitively in...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 31, 2018
|
| In: |
Journal of medicinal chemistry
Year: 2018, Jahrgang: 61, Heft: 20, Pages: 8981-9003 |
| ISSN: | 1520-4804 |
| DOI: | 10.1021/acs.jmedchem.8b00159 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1021/acs.jmedchem.8b00159
|
| Verfasserangaben: | Tianfang Ma, Fangxia Zou, Stefan Pusch, Yungen Xu, Andreas von Deimling, and Xiaoming Zha |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1670482723 | ||
| 003 | DE-627 | ||
| 005 | 20230426082349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190802s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acs.jmedchem.8b00159 |2 doi | |
| 035 | |a (DE-627)1670482723 | ||
| 035 | |a (DE-599)KXP1670482723 | ||
| 035 | |a (OCoLC)1341235176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ma, Tianfang |e VerfasserIn |0 (DE-588)1162345403 |0 (DE-627)1026003539 |0 (DE-576)507363353 |4 aut | |
| 245 | 1 | 0 | |a Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) |b an update and perspective |c Tianfang Ma, Fangxia Zou, Stefan Pusch, Yungen Xu, Andreas von Deimling, and Xiaoming Zha |
| 264 | 1 | |c May 31, 2018 | |
| 300 | |b Illustrationen | ||
| 300 | |a 23 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.08.2019 | ||
| 520 | |a Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However, mutant IDH1/2 (mIDH1/2) reduces α-KG to the oncometabolite 2-hydroxyglutarate (2-HG). High levels of 2-HG competitively inhibit the α-KG-dependent dioxygenases involved in histone and DNA demethylation, thereby impairing normal cellular differentiation and promoting tumor development. Thus, small molecules that inhibit these mutant enzymes may be therapeutically beneficial. Recently, an increasing number of mIDH1/2 inhibitors have been reported. In this review, we summarize the molecular basis of mIDH1/2 and the activity, binding modes, and progress in clinical application of mIDH1/2 inhibitors. We note important future research directions for mIDH1/2 inhibitors and discuss potential therapeutic strategies for the development of mIDH1/2 inhibitors to treat IDH1/2 mutated tumors. | ||
| 700 | 1 | |a Zou, Fangxia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pusch, Stefan |d 1979- |e VerfasserIn |0 (DE-588)137014155 |0 (DE-627)58945224X |0 (DE-576)30150623X |4 aut | |
| 700 | 1 | |a Xu, Yungen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Zha, Xiaoming |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Washington, DC : ACS, 1959 |g 61(2018), 20, Seite 8981-9003 |h Online-Ressource |w (DE-627)302468846 |w (DE-600)1491411-6 |w (DE-576)090855132 |x 1520-4804 |7 nnas |a Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) an update and perspective |
| 773 | 1 | 8 | |g volume:61 |g year:2018 |g number:20 |g pages:8981-9003 |g extent:23 |a Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) an update and perspective |
| 856 | 4 | 0 | |u https://doi.org/10.1021/acs.jmedchem.8b00159 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190802 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 137014155 |a Pusch, Stefan |m 137014155:Pusch, Stefan |d 910000 |d 912000 |e 910000PP137014155 |e 912000PP137014155 |k 0/910000/ |k 1/910000/912000/ |p 3 | ||
| 999 | |a KXP-PPN1670482723 |e 3503232435 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"23 S.","noteIll":"Illustrationen"}],"title":[{"title_sort":"Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2)","subtitle":"an update and perspective","title":"Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2)"}],"relHost":[{"note":["Gesehen am 02.10.2020"],"pubHistory":["1.1959 -"],"language":["eng"],"disp":"Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) an update and perspectiveJournal of medicinal chemistry","name":{"displayForm":["American Chemical Society"]},"origin":[{"publisher":"ACS ; ACS","dateIssuedDisp":"1959-","publisherPlace":"Washington, DC ; Easton, Pa.","dateIssuedKey":"1959"}],"recId":"302468846","id":{"issn":["1520-4804"],"eki":["302468846"],"zdb":["1491411-6"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of medicinal chemistry","title_sort":"Journal of medicinal chemistry"}],"part":{"text":"61(2018), 20, Seite 8981-9003","volume":"61","extent":"23","pages":"8981-9003","year":"2018","issue":"20"}}],"person":[{"given":"Tianfang","role":"aut","family":"Ma","display":"Ma, Tianfang"},{"family":"Zou","role":"aut","display":"Zou, Fangxia","given":"Fangxia"},{"given":"Stefan","display":"Pusch, Stefan","role":"aut","family":"Pusch"},{"given":"Yungen","display":"Xu, Yungen","family":"Xu","role":"aut"},{"family":"Deimling","role":"aut","display":"Deimling, Andreas von","given":"Andreas von"},{"given":"Xiaoming","role":"aut","family":"Zha","display":"Zha, Xiaoming"}],"note":["Gesehen am 02.08.2019"],"language":["eng"],"name":{"displayForm":["Tianfang Ma, Fangxia Zou, Stefan Pusch, Yungen Xu, Andreas von Deimling, and Xiaoming Zha"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"May 31, 2018"}],"id":{"doi":["10.1021/acs.jmedchem.8b00159"],"eki":["1670482723"]},"recId":"1670482723","type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a MATIANFANGINHIBITORS3120 | ||